about
Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine PhysiciansEfficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulationHemostasis in liver transplantation: Pathophysiology, monitoring, and treatmentReversal of oral anticoagulationTransfusion and coagulation management in liver transplantationBenefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis.Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patientsEmergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage.Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial.Budget impact analysis of warfarin reversal therapies among hip fracture patients in Finland.Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery.Clinical use and the Italian demand for prothrombin complex concentratesPerioperative neonatal and paediatric blood transfusion.Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding.eComment. Anticoagulation after intracranial haemorrhage in patients with a high risk of thrombosis.Managing a Rivaroxaban Bleed: Understanding the Difficulties in Acute Reversal of the New Oral Anticoagulants through a Case Report.Plasma Exchange for Urgent Apixaban Reversal in a Case of Hemorrhagic Tamponade after Pacemaker Implantation.Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery.Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis?
P2860
Q26746917-97D40F44-8698-4757-8B01-6AABAB9D5D0BQ26749141-B3941CB2-14EB-447F-9450-DE2A3137C776Q26773233-5289E1DE-3F66-4063-859A-A4D4510F8826Q26827835-D8124E9E-BBA4-4621-8816-9C212D158D07Q26995591-76868829-3A61-4AEA-BB4A-6D7A60EC1BB6Q30234372-61DEC1A6-C793-4377-B0E9-F13793D4B0A7Q33430766-890EC0CE-89CD-4DA0-B774-46C4AAC5E406Q34250328-8B6380DF-C49E-4417-8C9B-212EEB1C63DBQ34485905-2AA6FB98-247E-456C-A115-C5BA7D91E85BQ34626482-D9CF77A9-A863-4E60-88D1-355AC6410F2DQ34788255-81BCFED0-6576-4DB9-9155-11F658818948Q35175908-33AA0DFA-B13C-45E5-8607-7AB6D12D8F77Q36433257-71B1CE90-7311-4591-BED7-C0FA00DEF285Q37370338-40765BF1-7565-4CAE-932F-E71AF000A2FFQ38298666-B62F8574-9894-4500-9F7C-B58E528902CBQ38660256-8149E1C0-FBBF-4A5A-91D7-8DF7E479FA0FQ41107051-AE6CBA02-4E99-443E-84FE-8F011F7DE617Q42007287-C6E94867-5A85-4FB5-8A91-9C60E65FA7B1Q42072098-F54157F9-C793-4646-9E83-9EFB6AA43BBBQ48247692-693EB0BD-BEC7-47BA-9C68-76BB867EED1FQ51332285-6CE86B55-EC91-4B1C-BC80-A3C93B57BEFD
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prothrombin complex concentrates: an update.
@ast
Prothrombin complex concentrates: an update.
@en
Prothrombin complex concentrates: an update.
@nl
type
label
Prothrombin complex concentrates: an update.
@ast
Prothrombin complex concentrates: an update.
@en
Prothrombin complex concentrates: an update.
@nl
prefLabel
Prothrombin complex concentrates: an update.
@ast
Prothrombin complex concentrates: an update.
@en
Prothrombin complex concentrates: an update.
@nl
P2860
P356
P1476
Prothrombin complex concentrates: an update.
@en
P2860
P304
P356
10.2450/2010.0149-09
P577
2010-07-01T00:00:00Z